| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |